3D-QSAR and molecular docking studies of aminothiazole derivatives as Lim kinase 1 inhibitors Scientific paper

Main Article Content

Jing-Xuan Hou
https://orcid.org/0000-0003-2767-0795
Qing-Shan Gu
https://orcid.org/0000-0003-0273-801X
Meiqi Shi
https://orcid.org/0000-0001-9305-9551
Hui Gao
https://orcid.org/0000-0002-9158-3445
Lu Zheng
https://orcid.org/0000-0001-9906-938X
Qing-Kun Wu
https://orcid.org/0000-0001-6878-4508

Abstract

Lim kinase (Limk), as an important cytoskeletal regulator, plays an important role in cancer manifestations and neuronal diseases. Limk1 is a member of the Limk family, which is mainly involved in the invasion and metastasis of tumor cells and is abnormally expressed in a variety of cell carcinoma tissues. In this paper, a series of Limk1 inhibitors with aminothiazole skeleton were used to design potent and efficient Limk1 inhibitors by computational approaches. Firstly, the 3D-QSAR model was constructed, and both CoMFA and CoMSIA models have good correlationship and prediction ability. The binding requirements between ligand and receptor protein were then further explored through molecular docking, including the critical forces between Limk1 inhibitors and active site residues. Finally, based on the 3D-QSAR model and molecular docking results analysis, three new compounds with theoretically better activity were designed and their ADME properties were predicted.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
[1]
J.-X. Hou, Q.-S. Gu, M. Shi, H. Gao, L. Zheng, and Q.-K. Wu, “3D-QSAR and molecular docking studies of aminothiazole derivatives as Lim kinase 1 inhibitors: Scientific paper”, J. Serb. Chem. Soc., Sep. 2022.
Section
Theoretical Chemistry

References

K. Yoshioka, V. Foletta, O. Bernard, K. Itoh, Proc. Natl. Acad. Sci. 100 (2003) 7247–7252 (https://doi.org/10.1073/pnas.1232344100)

C. Prunier, R. Prudent, R. Kapur, K. Sadoul, L. Lafanechère, Oncotarget 8 (2017) 41749 (https://doi.org/10.18632/oncotarget.16978)

F. Yi, J. Guo, D. Dabbagh, M. Spear, S. He, K. Kehn-Hall, J. Fontenot, Y. Yin, M. Bibian, C. M. Park, J. Virol. 91 (2017) e02418-16 (https://doi.org/10.1128/JVI.02418-16)

F. Manetti, Drug Discov. Today 17 (2012) 81–88 (https://doi.org/10.1016/j.drudis.2011.08.004)

A. Jayo, M. Parsons, J. C. Adams, BMC Biol. 10 (2012) 1–19 (https://doi.org/10.1186/1741-7007-10-72)

D. H. Vlecken, C. P. Bagowski, Zebrafish 6 (2009) 433–439 (https://doi.org/10.1089/zeb.2009.0602)

O. Bernard, Int. J. Biochem. Cell Biol. 39 (2007) 1071–1076 (https://doi.org/10.1016/j.biocel.2006.11.011)

P. Chen, M. Zeng, Y. Zhao, X. Fang, Oncol. Rep. 32 (2014) 2070–2076 (https://doi.org/10.3892/or.2014.3461)

J. Zhou, R. Liu, C. Luo, X. Zhou, K. Xia, X. Chen, M. Zhou, Q. Zou, P. Cao, K. Cao, Cancer Biol. Ther. 15 (2014) 1340–1349 (https://doi.org/10.4161/cbt.29821)

P. Ross-Macdonald, H. de Silva, Q. Guo, H. Xiao, C.-Y. Hung, B. Penhallow, J. Markwalder, L. He, R. M. Attar, T. Lin, Mol. Cancer Ther. 7 (2008) 3490–3498 (https://doi.org/10.1158/1535-7163.MCT-08-0826)

B. E. Sleebs, G. Nikolakopoulos, I. P. Street, H. Falk, J. B. Baell, Bioorg. Med. Chem. Lett. 21 (2011) 5992–5994 (https://doi.org/10.1016/j.bmcl.2011.07.050)

Y. Yin, K. Zheng, N. Eid, S. Howard, J.-H. Jeong, F. Yi, J. Guo, C. M. Park, M. Bibian, W. Wu, J. Med. Chem. 58 (2015) 1846–1861 (https://doi.org/10.1021/jm501680m)

M. D. Charles, J. L. Brookfield, T. C. Ekwuru, M. Stockley, J. Dunn, M. Riddick, T. Hammonds, E. Trivier, G. Greenland, A. C. Wong, J. Med. Chem. 58 (2015) 8309–8313 (https://doi.org/10.1021/acs.jmedchem.5b01242)

K. Mardilovich, M. Baugh, D. Crighton, D. Kowalczyk, M. Gabrielsen, J. Munro, D. R. Croft, F. Lourenco, D. James, G. Kalna, Oncotarget 6 (2015) 38469 (https://doi.org/10.18632/oncotarget.6288)

M. Zhang, J. Tian, R. Wang, M. Song, R. Zhao, H. Chen, K. Liu, J.-H. Shim, F. Zhu, Z. Dong, Front. Cell Dev. Biol. (2020) 1361 (https://doi.org/10.3389/fcell.2020.556532)

X. Xu, B. Xu, X. Wang, & J. Li, J. Mol. Struct. 1201 (2020) 127128 (https://doi.org/10.1016/j.molstruc.2019.127128)

M. Sari-Hassoun, M.-J. Clement, I. Hamdi, G. Bollot, C. Bauvais, V. Joshi, F. Toma, A. Burgo, M. Cailleret, M. C. Rosales-Hernández, Biochem. Pharmacol. 102 (2016) 45–63 (https://doi.org/10.1016/j.bcp.2015.12.013)

A. Daina, O. Michielin, V. Zoete, Sci. Rep. 7 (2017) 1–13 (https://doi.org/10.1038/srep42717)

W. J. Egan, K. M. Merz, J. J. Baldwin, J. Med. Chem. 43 (2000) 3867–3877 (https://doi.org/10.1021/jm000292e).